On December 1, 2008, Johnson & Johnson announced its entry into a definitive agreement whereby it will acquire Mentor Corporation, a leading supplier of medical products for the global aesthetic market, for approximately $1.1 billion in a cash tender offer. Under the terms of the agreement, Johnson & Johnson will commence a tender offer to purchase all outstanding shares of Mentor at $31 per share. The tender offer is expected to close during the first quarter of 2009. Mentor is expected to operate as a stand-alone business unit reporting through ETHICON, Inc., a Johnson & Johnson company and a leading provider of suture, mesh and other products for a wide range of surgical procedures.
The lawyers involved are associates Leigh M. Harlan and Ryan D. Gorsche on corporate matters; partner Eric W. Hilfers and associates Lori Diamond Goodman and Jarrett R. Hoffman on executive compensation and benefits matters; and senior attorney Gregory J. Battista on environmental matters.
Deals & Cases
March 12, 2025
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.